| A microfluidically perfused three dimensional human liver model K Rennert, S Steinborn, M Gröger, B Ungerböck, AM Jank, J Ehgartner, ... Biomaterials 71, 119-131, 2015 | 273 | 2015 |
| A three-dimensional immunocompetent intestine-on-chip model as in vitro platform for functional and microbial interaction studies M Maurer, MS Gresnigt, A Last, T Wollny, F Berlinghof, R Pospich, ... Biomaterials 220, 119396, 2019 | 138 | 2019 |
| Keeping Candida commensal: how lactobacilli antagonize pathogenicity of Candida albicans in an in vitro gut model K Graf, A Last, R Gratz, S Allert, S Linde, M Westermann, M Gröger, ... Disease models & mechanisms 12 (9), dmm039719, 2019 | 68 | 2019 |
| Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model M Gröger, K Rennert, B Giszas, E Weiß, J Dinger, H Funke, M Kiehntopf, ... Scientific reports 6 (1), 1-16, 2016 | 59 | 2016 |
| Preservation of cell structure, metabolism, and biotransformation activity of liver‐on‐chip organ models by hypothermic storage M Gröger, J Dinger, M Kiehntopf, FT Peters, U Rauen, AS Mosig Advanced healthcare materials 7 (2), 1700616, 2018 | 31 | 2018 |
| Recruitment of CD16+ monocytes to endothelial cells in response to LPS-treatment and concomitant TNF release is regulated by CX3CR1 and interfered by soluble fractalkine K Rennert, K Heisig, M Groeger, M Wallert, H Funke, S Lorkowski, ... Cytokine 83, 41-52, 2016 | 21 | 2016 |
| Human macrophage polarization determines bacterial persistence of Staphylococcus aureus in a liver-on-chip-based infection model F Siwczak, Z Cseresnyes, MIA Hassan, KO Aina, S Carlstedt, A Sigmund, ... Biomaterials 287, 121632, 2022 | 18 | 2022 |
| CAAP48, a New Sepsis Biomarker, Induces Hepatic Dysfunction in an in vitro Liver-on-Chip Model N Blaurock-Möller, M Gröger, F Siwczak, J Dinger, D Schmerler, AS Mosig, ... Frontiers in Immunology 10, 273, 2019 | 14 | 2019 |
| A new fluorescent dye for cell tracing and mitochondrial imaging in vitro and in vivo AT Press, L Ungelenk, AC Rinkenauer, M Gröger, F Lehmann, A Mosig, ... Journal of biophotonics 9 (9), 888-900, 2016 | 8 | 2016 |
| Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages M Groeger, K Matsuo, E Heidary Arash, A Pereira, D Le Guillou, C Pino, ... Nature communications 14 (1), 3902, 2023 | 7 | 2023 |
| Human iPSC‐Derived Proinflammatory Macrophages cause Insulin Resistance in an Isogenic White Adipose Tissue Microphysiological System L Qi, K Matsuo, A Pereira, YT Lee, F Zhong, Y He, PJH Zushin, M Gröger, ... Small 19 (34), 2203725, 2023 | 5 | 2023 |
| Novel approach for the prediction of cell densities and viability in standardized translucent cell culture biochips with near infrared spectroscopy M Gröger, M Lange, K Rennert, T Kaschowitz, H Plettenberg, M Hoffmann, ... Engineering in Life Sciences 17 (5), 585-593, 2017 | 4 | 2017 |
| Functional integration of natural killer cells in a microfluidically perfused liver on-a-chip model R Fahrner, M Gröger, U Settmacher, AS Mosig BMC research notes 16 (1), 285, 2023 | 2 | 2023 |
| Adipocyte inflammation is the primary driver of hepatic insulin resistance in a human iPSC-based microphysiological system L Qi, M Groeger, A Sharma, I Goswami, E Chen, F Zhong, A Ram, K Healy, ... Nature Communications 15 (1), 7991, 2024 | | 2024 |
